重新思考癌症计划的方法

Same author

War, bioterrorism, and the political landscape.

Lancet (London, England)·2002

Same author

Blood, politics, and the American Red Cross.

Lancet (London, England)·2001

Same author

US anthrax scares prompt action on bioterrorism.

Lancet (London, England)·2001

Same author

US reacts to anxiety about biological attacks.

Lancet (London, England)·2001

Same author

Presidential and Congressional responses as a nation reels after the attacks.

Lancet (London, England)·2001

Same author

Bush stem-cell plans draw scepticism in Senate.

Lancet (London, England)·2001

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

相关实验视频

重新思考癌症计划的方法

相关概念视频

War, bioterrorism, and the political landscape.

Blood, politics, and the American Red Cross.

US anthrax scares prompt action on bioterrorism.

US reacts to anxiety about biological attacks.

Presidential and Congressional responses as a nation reels after the attacks.

Bush stem-cell plans draw scepticism in Senate.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

相关实验视频

重新思考癌症计划的方法

相关概念视频

相关文章

War, bioterrorism, and the political landscape.

Blood, politics, and the American Red Cross.

US anthrax scares prompt action on bioterrorism.

US reacts to anxiety about biological attacks.

Presidential and Congressional responses as a nation reels after the attacks.

Bush stem-cell plans draw scepticism in Senate.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.